High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli.
about
Inhibition of the Hantavirus Fusion Process by Predicted Domain III and Stem Peptides from Glycoprotein GcRecombinant multiepitope protein for early detection of dengue infections.An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypesSingle Antigen Detects both Immunoglobulin M (IgM) and IgG Antibodies Elicited by All Four Dengue Virus SerotypesDomain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusionHumanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In VivoDNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III.Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus.Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris.Dengue vaccine: priorities and progress.Dengue in India.Induction of partial protection against foot and mouth disease virus in guinea pigs by neutralization with the integrin β6-1 subunit.Domain III of the envelope protein as a dengue vaccine target.Fight against dengue in India: progresses and challenges.Key concepts, strategies, and challenges in dengue vaccine development: an opportunity for sub-unit candidates?Production of dengue virus envelope protein domain III-based antigens in tobacco chloroplasts using inducible and constitutive expression systems.Dengue virus type-3 envelope protein domain III; expression and immunogenicity.Construction of recombinant Kluyveromyces marxianus UFV-3 to express dengue virus type 1 nonstructural protein 1 (NS1).Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli.Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli.Cloning and characterization of the Cerasus humilis sucrose phosphate synthase gene (ChSPS1).A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.Overexpression and purification of folded domain of prostate cancer related proteins MSMB and PSA.Dengue envelope-based 'four-in-one' virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice.
P2860
Q26700097-1328FC94-921D-43BD-913E-7B43ACB54182Q27472835-207A21F0-E34A-4887-8B76-CC34291A4FD8Q27478104-0F9A419E-A9AC-45AC-9519-864CD2CC2401Q27484622-D967FD1C-1AB3-4AE4-948B-5EF9D618D813Q27485039-A0934ACB-E3AC-4BAB-AD56-0115A633FCE4Q27486404-9FCF4662-4100-4B93-A62F-EAD17128E793Q33968024-95E9678F-AD3E-4FC3-A8A0-530267E41574Q34354665-8EAABC98-2411-4616-9B77-F3BAED77896EQ34408025-856AD579-4856-4B24-B6FE-C8D6B0F09D63Q35915029-555035FA-D779-49AA-8093-2D87A062010DQ35964754-7B8E5B97-BD7E-4E14-A17B-E3D80B87FAB5Q36436289-C8E94934-8622-4079-98AC-F8B03DFCA6DAQ36993842-FFDDFE89-100A-43CE-A046-D91888145CC0Q37682895-E965F58F-AAF7-4BD5-9B88-ABF47FA8D434Q38086052-D06FA3C7-F41A-4AEE-8AB7-3031E1A4028DQ38618056-4EFF31ED-B4EC-47DC-A10D-6F357B668475Q39029884-EAD8807A-CC49-4D86-8083-777910CA52B2Q40168970-D0DF2C07-1A0A-4E23-A65C-24808D8869ACQ40198225-31F93AE7-1080-4495-9C6A-D7FA3DE7E680Q40293191-1B06DA74-98ED-4570-92BE-1816B1EED147Q40326193-CD35201C-60A8-4605-91F9-31E9A79BF07AQ42695857-63A73A57-279D-4AE0-BCF7-F6B733BD08C5Q47194469-0E9AB7EB-80E5-4F92-A7ED-DE44BD842F16Q51399248-119C0383-5D0A-41B8-BE1A-D0FF82166E3AQ55244392-92CCD4CD-B7F9-4143-812E-769455C2B667
P2860
High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
High-level expression and one- ...... I protein in Escherichia coli.
@en
type
label
High-level expression and one- ...... I protein in Escherichia coli.
@en
prefLabel
High-level expression and one- ...... I protein in Escherichia coli.
@en
P2093
P1476
High-level expression and one- ...... I protein in Escherichia coli.
@en
P2093
Navin Khanna
Sathyamangalam Swaminathan
Smita Jaiswal
P356
10.1016/J.PEP.2003.09.009
P577
2004-01-01T00:00:00Z